Evaluate the Effect of Tirazamine on Primary Liver Cancer.
Clinical trial NCT06848556 · TERMINATED
Trial details
- NCT number
- NCT06848556
- Sponsor
- Zhejiang Raygene Pharmaceuticals Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-14
- Primary completion
- 2023-11-06
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.